METABOLIC BRAIN DISEASE, published by SPRINGER/PLENUM PUBLISHERS, is a leading journal dedicated to advancing our understanding of the metabolic processes impacting brain health and disease. Established in 1986 and set to continue until 2024, this journal encompasses a wide range of interdisciplinary research that intersects the fields of Biochemistry, Cellular and Molecular Neuroscience, and Neurology, as evidenced by its notable quartile placements in Q2 and Q3 for 2023. With an ISSN of 0885-7490 and an E-ISSN of 1573-7365, it serves as a vital resource for researchers and practitioners aiming to deepen their insights into cerebral metabolic disorders and their implications. Although currently not an Open Access option, its rigorous peer-review process ensures that high-quality, impactful research reaches its audience. Showcasing a significant rank within the top percentile of its categories, METABOLIC BRAIN DISEASE is instrumental in shaping the future of neurological research and clinical applications.

ACTA NEUROLOGICA BELGICA is a leading academic journal published by Springer Heidelberg, dedicated to advancing the field of neurology and medicine. With an ISSN of 0300-9009 and E-ISSN 2240-2993, this journal has been a vital resource since its inception, contributing significantly to neurological research and clinical practice. It holds a respectable impact factor with categories spanning from Q2 in Medicine (miscellaneous) to Q3 in Neurology (clinical) as of 2023, indicating its prominence in the scientific community. The journal's extensive coverage since 1959 enhances its historical relevance, while its ongoing publication until 2024 ensures the latest developments are readily accessible. Researchers and practitioners can benefit from its rigorous peer-reviewed articles, which are crucial for staying current in this rapidly evolving discipline. As a scholarly platform, ACTA NEUROLOGICA BELGICA plays a pivotal role in disseminating knowledge and fostering innovation in neurology, making it a must-read for professionals, students, and anyone involved in the field.

The Journal of Epidemiology and Global Health (ISSN: 2210-6006; E-ISSN: 2210-6014), published by SpringerNature, stands as a premier open-access platform in the field of epidemiology, dedicated to advancing our understanding of global health challenges since 2011. Based in Switzerland, this journal is recognized for its significant contributions to the discipline, achieving an impressive Q1 ranking in Epidemiology and positioning itself at the 88th percentile within the Scopus Medicine - Epidemiology category. With a goal to disseminate innovative research and foster dialogue among scholars, public health professionals, and students, the journal provides a rich repository of empirical studies, reviews, and theoretical contributions that address pressing epidemiological issues. Its commitment to open access ensures that vital research is freely available to the global community, thereby amplifying its impact and relevance. Researchers seeking to publish and access high-quality, peer-reviewed articles will find the Journal of Epidemiology and Global Health an invaluable resource in navigating the ever-evolving landscape of public health.

Seminars in Pediatric Neurology, published by W B SAUNDERS CO-ELSEVIER INC, is a prestigious journal dedicated to the evolving field of pediatric neurological disorders. Since its inception in 1994, this peer-reviewed journal has provided critical insights and cutting-edge research to support healthcare professionals in enhancing the quality of care for children with neurological conditions. With an impressive 2023 impact factor and a Q2 ranking in both the clinical neurology and pediatrics categories, it stands as a vital resource, fostering the dissemination of knowledge among researchers and clinicians alike. Featuring articles that explore a range of topics from clinical trials to innovative treatment modalities, this journal empowers practitioners with the latest findings in pediatric neurology. While primarily subscription-based, it plays a key role in bridging the gap between academia and clinical practice, making it an indispensable tool for anyone involved in the care and treatment of pediatric neurological patients.

The Journal of Clinical Neurology, published by the Korean Neurological Association, is a prominent open-access journal that has been disseminating crucial findings in the field of neurology since its inception in 2008. With an ISSN of 1738-6586 and an E-ISSN of 2005-5013, this journal provides a vital platform for researchers and clinicians to share innovative research, reviews, and case studies that advance understanding and treatment of neurological disorders. The journal has established its reputation, achieving a Q3 ranking in Neurology and a Q2 ranking in Clinical Neurology in 2023, placing it among the noteworthy sources in the medical community. With its open-access format since 2011, it facilitates broad dissemination of knowledge to both the scientific community and the public, supporting the journal's mission to enhance clinical practice and promote neurological health in South Korea and beyond. As of October 2023, it holds influential Scopus ranks, reflecting its impact and relevance in the ever-evolving landscape of neuroscience. Researchers, professionals, and students alike are encouraged to contribute to and engage with the ongoing discourse by submitting their work and accessing a wealth of resources through this esteemed publication.

ACTA NEUROLOGICA SCANDINAVICA is a prestigious journal published by Wiley that has significantly contributed to the field of neurology and neuroscience since its inception in 1961. With a broad scope encompassing clinical and experimental research, this journal is esteemed for its rigorous peer-review process and high-quality publications. Located in the United Kingdom, it is recognized in the 2023 category quartiles as Q1 in Medicine (miscellaneous) and Q2 in both Neurology and Clinical Neurology, indicating its strong influence and relevance within the medical community. With an H-index demonstrating consistent citation impact, ACTA NEUROLOGICA SCANDINAVICA holds a Scopus rank of #86 out of 400 in Clinical Neurology, reflecting its contribution to advancing current knowledge and practice. Researchers, professionals, and students alike will find in this journal a valuable resource for the latest findings, discussions, and developments in understanding neurological disorders and treatments, furthering educational and clinical endeavors alike.

DM DISEASE-A-MONTH is a leading monthly journal published by MOSBY-ELSEVIER, dedicated to disseminating pivotal research and insights across the spectrum of general medicine. With a history spanning from 1954 to 2024, this journal has established itself as a key resource within the field, reflecting its commitment to advancing medical knowledge and practice. As evidenced by its impressive Scopus ranking—currently at #79 out of 636 in General Medicine and falling within the 87th percentile—this journal occupies a prominent position in the medical literature landscape. Although not an open-access publication, DM DISEASE-A-MONTH continues to serve a diverse audience of researchers, healthcare professionals, and medical students, providing valuable updates on recent advances in medicine and enabling its readers to stay informed about emerging trends and critical health issues. Its current Q2 category ranking in the 2023 Medical (miscellaneous) field further underscores its relevance and impact, making it an essential addition to the library of any medical practitioner or researcher.

Current Neurology and Neuroscience Reports, published by Springer, is a leading peer-reviewed journal dedicated to advancing the field of neurology and neuroscience. With a notable impact factor and a reputable standing in the academic community, as evidenced by its Q1 rankings in both Neurology (Clinical) and Neuroscience (Miscellaneous) for 2023, this journal is ranked #49 out of 400 in clinical neurology and #21 out of 113 in general neuroscience, placing it in the 87th and 81st percentiles respectively.

Since its inception in 2001, it has provided a platform for groundbreaking research, comprehensive reviews, and critical insights into contemporary issues affecting the nervous system. Aimed at researchers, clinicians, and students alike, Current Neurology and Neuroscience Reports fosters interdisciplinary dialogue and knowledge exchange, addressing a broad spectrum of topics from clinical neurology to theoretical neuroscience. By publishing high-quality research, the journal not only contributes to the scientific community but also aims to enhance patient care and inform clinical practices. As a vital resource in neurological research, it invites contributions from a diverse range of studies to expand understanding in this ever-evolving field.

Canadian Journal of Neurological Sciences, published by Cambridge University Press, stands as a reputable source of knowledge in the field of neurology, dedicated to advancing research and clinical practice. With an ISSN of 0317-1671 and an E-ISSN of 2057-0155, this journal has been a cornerstone for the exchange of ideas since its inception in 1974 and will continue to cater to the academic community until 2024. Recognized in the top quartile (Q2) in various categories including Medicine (miscellaneous) and Neurology (clinical), its articles engage a broad audience, ranging from established researchers to students seeking to deepen their understanding of neurological sciences. Although the journal is not an open-access publication, it provides vital insights and research findings that contribute significantly to its fields. With a Scopus rank of #183 in clinical neurology and a percentile ranking that reflects its commendable standing, the Canadian Journal of Neurological Sciences is indispensable for those committed to the exploration and treatment of neurological disorders.

Egyptian Journal of Neurology Psychiatry and Neurosurgery, published by Springer, is a premier open-access journal that has been dedicated to advancing the fields of neurology, psychiatry, and neurosurgery since its inception in 2009. With an E-ISSN of 1687-8329, this journal aims to provide a dynamic platform for researchers and clinicians to disseminate their findings, fostering a rich dialogue on the latest developments and innovations within these critical disciplines. With an impactful open-access model adopted since 2018, the journal attracts a global audience, facilitating the exchange of knowledge and ideas across various medical and scientific landscapes. In the 2023 rankings, it holds impressive positions within the Q3 category for Neurology (clinical), Psychiatry and Mental Health, and Surgery, as well as Q4 in Miscellaneous Neuroscience, highlighting its value within the field. As a valuable resource for both budding scholars and seasoned professionals, the Egyptian Journal of Neurology Psychiatry and Neurosurgery offers insights that drive progress in the treatment and understanding of neurological and psychiatric conditions.